Ramaciotti Centre for Genomics, UNSW
The Ramaciotti Centre for Genomics is UNSW Sydney's university-operated core genomics facility, delivering fee-for-service next-generation sequencing, Sanger sequencing, microarray, single-cell, and bioinformatics services to academic, clinical, and industry clients across Australia under ISO/IEC 17025 accreditation.
- Company typePrivate
- Founded2000
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ramaciotti Centre for Genomics, UNSW does
The Ramaciotti Centre for Genomics is a university-operated core research facility within UNSW Sydney's Faculty of Science, established around 2000 and recognized as the largest genomics facility at any Australian university. It operates from UNSW's Kensington campus in Sydney, Australia, as part of the Mark Wainwright Analytical Centre research infrastructure network. The centre delivers fee-for-service genomic analysis to academic researchers, clinicians, and industry clients across Australia, and is credited as a service provider on 140+ peer-reviewed publications annually. It holds ISO/IEC 17025:2017 accreditation and is designated as research infrastructure of national significance.
The centre's technical platform centres on Illumina-based next-generation sequencing, supplemented by Sanger sequencing, high-throughput microarrays, whole-plasmid sequencing, and single-cell genomics capabilities. Services are organized into thematic categories covering genome and epigenome analysis, gene expression and transcriptomics, microbiome and metagenome analysis, accredited testing, and bioinformatics support. Sample intake is managed through a dedicated online submission portal with documented quality-control requirements and standard service terms. Marketing and customer-acquisition activity is conducted through organic social channels (LinkedIn, Facebook, Instagram, YouTube), email newsletters, and direct enquiry.
Commercially, the centre operates as a non-profit university facility under the University of New South Wales (a statutory public entity). Revenue is generated on a usage-based, quote-driven basis with no publicly disclosed pricing, and no external equity or venture funding is involved. The headcount stands at approximately 22 staff, and the facility has been operating continuously for over 25 years. Geographic scope is formally domestic, although institutional memberships in the Group of Eight Australia and Universitas 21 provide latent channels for international research collaboration.
Ramaciotti Centre for Genomics, UNSW firmographics
Firmographics- Name
- Ramaciotti Centre for Genomics, UNSW
- Legal name
- University of New South Wales (UNSW Sydney)
- Website
- https://ramaciotti.unsw.edu.au
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Ramaciotti Centre for Genomics is UNSW Sydney's university-operated core genomics facility, delivering fee-for-service next-generation sequencing, Sanger sequencing, microarray, single-cell, and bioinformatics services to academic, clinical, and industry clients across Australia under ISO/IEC 17025 accreditation.
- Ownership category
- akta.pro rank
Ramaciotti Centre for Genomics, UNSW industry classification
Industry- Product category
- Genomics Research Services
- NAICS
- Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industries
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
Keywords
Where Ramaciotti Centre for Genomics, UNSW is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Ramaciotti Centre for Genomics, UNSW business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Genomic Testing Services: Fee-for-service genomic analysis including next-generation sequencing, Sanger sequencing, microarrays, and bioinformatics. Clients include researchers, clinicians, and industry partners who submit samples for analysis.
- Accredited Testing Services: ISO/IEC 17025 accredited genomic testing services for certified analysis results
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Ramaciotti Centre for Genomics, UNSW product offering
Product offeringCore offering
The Ramaciotti Centre for Genomics provides fee-for-service genomic analysis to academic researchers, clinicians, and industry clients, including next-generation sequencing, Sanger sequencing, high-throughput microarrays, whole plasmid sequencing, single-cell genomics, accredited testing, and bioinformatics data interpretation. Clients submit samples through a dedicated portal and receive end-to-end services from sample processing through computational analysis.
Product overview
The Ramaciotti Centre for Genomics is a university-based core facility offering a comprehensive suite of genomic services. It operates as a multi-service platform providing Next Generation Sequencing, Sanger Sequencing, Microarrays, and Whole Plasmid Sequencing as its core technical services. These are organized into specialized service categories covering Genome & Epigenome, Gene Expression & Transcriptome, Microbiome & Metagenome, Single Cell, Accredited Services, and Bioinformatics. The centre serves researchers, clinicians, and industry clients, delivering world-class genomic services and expertise from sample submission through data analysis.
Differentiator
Problem solved
Functional benefit
Products and services
- Next Generation Sequencing
Quantifiable outcome
- Service provider on over 140 peer-reviewed publications annually
Companies that use Ramaciotti Centre for Genomics, UNSW
Customer profileSegments3 records
Ideal customer profiles3 records
Ramaciotti Centre for Genomics, UNSW technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Ramaciotti Centre for Genomics, UNSW partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- UNSW Faculty of SciencecoreThe centre is an integral part of the UNSW Faculty of Science, operating within the university's research infrastructure ecosystem. It is positioned within the School of Biotechnology and Biomolecular Sciences (BABS) cluster.
- Mark Wainwright Analytical Centre (MWAC)coreThe centre is part of UNSW's major research infrastructure network under MWAC, which provides centralised access to sophisticated analytical instruments and expertise across multiple disciplines.
- Group of Eight AustraliaminorUNSW is a member of the Group of Eight (Go8) coalition of leading Australian universities. The centre benefits from association with this prestigious university network and may collaborate on national research initiatives.
- Universitas 21minorUNSW is a member of Universitas 21, a global network of research-intensive universities. The centre may benefit from international research collaborations through this network.
Scale indicators4 records
Recent moves4 records
Expansion highlights4 records
Ramaciotti Centre for Genomics, UNSW competitors and assessment
Company assessmentEmerging players
- Centre for Population Genomics (Garvan/Murdoch Children's): Australian genomics initiative focused on large-scale population and clinical genomic sequencing. Comparable as an emerging player operating in adjacent segments of the Australian genomics services market that Ramaciotti serves.
- Pacific Biosciences (PacBio): Long-read sequencing technology provider whose HiFi sequencing is increasingly adopted by core facilities and service labs. Comparable as an emerging technology player whose platforms compete for sequencing budgets alongside the short-read services Ramaciotti runs.
Broad incumbents
- Illumina: Global leader in NGS instruments and reagents, supplier of the sequencer technology Ramaciotti relies on, and increasingly a competitor via its own service offerings (e.g., Illumina Connected Software). Comparable as the dominant industry incumbent shaping the genomics services landscape.
- Thermo Fisher Scientific – GeneArt & Sanger Services: Major life-sciences tools company with genomics reagents, instruments, and Sanger synthesis services used by academic and industry researchers. Comparable as a broad incumbent serving overlapping customers with sequencing-adjacent offerings.
- BGI Genomics: One of the world's largest genomics service providers with global sequencing capacity and aggressive pricing for academic and clinical customers. Comparable as a broad incumbent competing for outsourced NGS work at scale.
Direct peers
- Genewiz (Azenta Life Sciences): Commercial genomics services provider (formerly GENEWIZ) offering Sanger, NGS, and synthetic biology services globally. Comparable for outsourced Sanger and NGS fee-for-service work targeting the same researcher/industry client base.
- Garvan Institute of Medical Research – Genome Facility: Sydney-based medical research institute with significant in-house genomic sequencing capability serving clinical and translational researchers. Comparable because of overlapping service menu, geographic proximity, and shared institutional research clients.
- Australian Genome Research Facility (AGRF): Australia's other major genomics service facility offering NGS, Sanger, genotyping, and bioinformatics to academic and clinical clients nationwide. AGRF is the most direct domestic comparator given shared business model, customer base, and service portfolio.
- Novogene (Australia): Global commercial genomics service provider with NGS, Sanger, single-cell, and bioinformatics offerings to academic and industry clients in Australia. Comparable as a direct competitor for fee-for-service sequencing work, especially for industry contracts.
- Walter and Eliza Hall Institute of Medical Research (WEHI) – Genomics Facility: Melbourne-based medical research institute operating a genomics core serving academic and clinical users across Australia. Comparable due to similar core-facility model, NGS/Sanger service offerings, and academic client base.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Ramaciotti Centre for Genomics, UNSW social profiles
Digital presenceRamaciotti Centre for Genomics, UNSW compliance and trust
Trust signalCompliance1 record
Ramaciotti Centre for Genomics, UNSW financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ramaciotti Centre for Genomics, UNSW leadership team
Management profileNumber of profiles
Ramaciotti Centre for Genomics, UNSW funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ramaciotti Centre for Genomics, UNSW M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ramaciotti Centre for Genomics, UNSW
What does Ramaciotti Centre for Genomics, UNSW do?
The Ramaciotti Centre for Genomics provides fee-for-service genomic analysis to academic researchers, clinicians, and industry clients, including next-generation sequencing, Sanger sequencing, high-throughput microarrays, whole plasmid sequencing, single-cell genomics, accredited testing, and bioinformatics data interpretation. Clients submit samples through a dedicated portal and receive end-to-end services from sample processing through computational analysis.
Is Ramaciotti Centre for Genomics, UNSW a public or private company?
Ramaciotti Centre for Genomics, UNSW is a private company. It is classified as state government owned and is currently operating.
When was Ramaciotti Centre for Genomics, UNSW founded?
Ramaciotti Centre for Genomics, UNSW was founded in 2000. It employs 11 to 50 people.
Where is Ramaciotti Centre for Genomics, UNSW based?
Ramaciotti Centre for Genomics, UNSW is headquartered in Sydney, Australia, in the Oceania region.
How does Ramaciotti Centre for Genomics, UNSW make money?
Two revenue lines are on record. Genomic Testing Services are the primary driver. The others are accredited Testing Services.
Who are Ramaciotti Centre for Genomics, UNSW's main competitors?
Emerging players on record are Centre for Population Genomics (Garvan/Murdoch Children's) and Pacific Biosciences (PacBio). Broad incumbents are Illumina, Thermo Fisher Scientific – GeneArt & Sanger Services and BGI Genomics. Direct peers are Genewiz (Azenta Life Sciences), Garvan Institute of Medical Research – Genome Facility, Australian Genome Research Facility (AGRF), Novogene (Australia) and Walter and Eliza Hall Institute of Medical Research (WEHI) – Genomics Facility.
Does Ramaciotti Centre for Genomics, UNSW have an API?
No public API is recorded for Ramaciotti Centre for Genomics, UNSW.
What industry is Ramaciotti Centre for Genomics, UNSW in?
Ramaciotti Centre for Genomics, UNSW's product category is Genomics Research Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.